MarketersMEDIA / Newsroom / Neurodiagnostics Market to grow with CAGR of 7% during (2019-2026)- Exclusive Report by Brisk Insights

Neurodiagnostics Market to grow with CAGR of 7% during (2019-2026)- Exclusive Report by Brisk Insights

Share This Press Release

According to WHO, approximately 6 million deaths occur due to stroke each year. Furthermore, as per WHO, epilepsy is a common neurological disease and approximately 50 million people (as in 2016) globally suffer from epilepsy and 2.4 million people are diagnosed with epilepsy each year.

— The global market for neurodiagnostics is expected to grow during the forecast period (2019-2026) with a CAGR of around 7 percent. The major factors driving the global market are increasing geriatric population, increasing the adoption of new diagnostic technologies, increasing neurological disease prevalence. In addition, increasing the patient base in developing economies, innovative product development acts as the global market's key growth opportunities.

Full Report @ http://www.briskinsights.com/report/neurodiagnostics-market

In addition, neurological diseases such as Alzheimer's disease, migraine, Parkinson's disease, epilepsy, stroke, multiple sclerosis, neurodegeneration, etc. have increased the use of neurodiagnostic technologies to diagnose and treat neurological diseases. According to the World Health Organization (WHO), every year there are about 6 million deaths due to stroke. In addition, according to the WHO, epilepsy is a common neurological disease, with around 50 million people worldwide suffering from epilepsy (as in 2016) and 2.4 million people diagnosed with epilepsy each year. In addition, Alzheimer's disease has resulted in 7.7 million new cases of dementia each year, according to the WHO. In addition, according to the Reliant Medical Group Central Massachusetts Healthcare (US), neurological disorders such as strokes, neuropathy, Alzheimer's, etc. are highly prevalent among geriatric populations (over 65 years of age), as these diseases affect the central nervous system preferentially. According to the research alliance for aging, there were around 64,000 novel incidences of Alzheimer's in Americans aged 65–74, and 243,000 new cases in those 85 + years and around 173,000 new cases for 75-84 years. Someone in the U.S. develops Alzheimer's disease every 70 seconds. 16 percent of women aged 71 and older have Alzheimer's disease or other dementias compared to 11 percent of men.

Get Brochure PDF: http://www.briskinsights.com/sample-request/1670

The global market is segmented into the market for neurodiagnostic technologies based on segmentation. In-Vitro Diagnostics, Neuroimaging and Neuroinformatics are further sub-segmented in the technology segment. Neuroimaging is further divided into Magnetic Resonance Imaging, Computed Tomography, Near Infrared Spectroscopic Imaging, Nuclear Medicine Imaging, Electroencephalography, Voxel-based Morphometry and Magnetoencephalography.

The global neurodiagnostic market is segmented into North America, Europe, Asia Pacific, and Row based on geography and geography. It is expected that North America will have the largest market share in the period 2019-2026. The North American Neurodiagnostic market is driven mainly by the growing geriatric population considering escalating cases of Alzheimer's and Parkinson's disease that occurs most in the elderly, along with investments made by government institutions in Alzheimer's disease research and development activities. An estimated 5.7 million U.S. population combining all age groups is living with Alzheimer's dementia in 2018, according to the Alzheimer's Association. Furthermore, during the forecast period (2019-2026), Asia Pacific is expected to be the fastest growing region. The influence of the government on the healthcare sector and the increasing number of neuro-specialty clinics in numerous hospitals are the main factor stimulating the growth of the market.

Some of the major players of the market are Alpha Omega Ltd. (Germany), Agilent Technologies (United States), Bruker (United States), Fonar Corporation (United States), GE Healthcare (United States), Siemens Healthcare (Germany), Hitachi Medical Corporation (Japan), Hologic, Inc. (United States), Neusoft Medical Systems Co., Ltd. (United States), Roche Diagnostics (Switzerland) and Others. These companies use various strategies such as merger & acquisition, collaboration, partnership and product launch. For instance; For instance; in 2018, Brain Vision Solutions launched a high-density wireless EEG solution LiveAmp 64.

Get Brochure PDF: http://www.briskinsights.com/sample-request/1670

ToC:
1. Preface
..............
2. Executive Summary
.........
3. Market Dynamics
..........
4. Global Neurodiagnostics Market, by Application
4.1. Overview
4.1.1. Global Neurodiagnostics Market Value Share, by Application, 2018 & 2026 (Value, %)
4.1.2. Global Neurodiagnostics Market, by Application, 2019-2026 (US$ Mn)
4.2. In Vitro Diagnostics
4.2.1. Global Neurodiagnostics Market for In Vitro Diagnostics, 2019-2026 (US$ Mn)
4.2.2. Global Neurodiagnostics Market for In Vitro Diagnostics, by Region 2019-2026 (US$ Mn)
4.3. Neuroinformatics
4.3.1. Global Neurodiagnostics Market for Neuroinformatics, 2019-2026 (US$ Mn)
4.3.2. Global Neurodiagnostics Market for Neuroinformatics, by Region 2019-2026 (US$ Mn)
4.4. Neuroimaging
4.4.1. Market Determinants (Drivers, Restraints, Challenges & Opportunity)
4.4.2. Global Neurodiagnostics Market for Neuroimaging, 2019-2026 (US$ Mn)
4.4.3. Global Neurodiagnostics Market for Neuroimaging, by Region 2019-2026 (US$ Mn)
4.4.4. Sub Segments
4.4.4.1. Magnetic Resonance Imaging
4.4.4.2. Computed Tomography
4.4.4.3. Nuclear Medicine Imaging
4.4.4.4. Electroencephalography
4.4.4.5. Near Infrared Spectroscopic Imaging
4.4.4.6. Voxel-based Morphometry
4.4.4.7. Magnetoencephalography

5. North America Neurodiagnostics Market Analysis
.............
6. Europe Neurodiagnostics Market Analysis
............
7. Asia Pacific Neurodiagnostics Market Analysis
................
8. Rest of the World Neurodiagnostics Market Analysis
...........
9. Company Profiles
9.1. Alpha Omega Ltd. (Germany)
9.2. Agilent Technologies (United States)
9.3. Bruker (United States)
9.4. Fonar Corporation (United States)
9.5. GE Healthcare (United States)
9.6. Siemens Healthcare (Germany)
9.7. Hitachi Medical Corporation (Japan)
9.8. Hologic, Inc. (United States)
9.9. Neusoft Medical Systems Co., Ltd.(United States)
9.10. Roche Diagnostics (Switzerland)
......................toc continued

Full Report @ http://www.briskinsights.com/report/neurodiagnostics-market

About Us
Brisk Insights is a global market research firm. Our insightful analysis is focused on developed and emerging markets. We identify trends and forecast markets with a view to aid businesses identify market opportunities optimize strategies.
Our team of 200 analysts’ provides enterprises with strategic insights. Brisk Insights works to help enterprises grow through strategic insights and actionable solutions

Contact Info:
Name: Kevin Wilson
Email: Send Email
Organization: Brisk Insights
Address: Office 1094, 109 Vernon House, Friar Lane, ,
Phone: 18003618290
Website: http://www.briskinsights.com

Source URL: https://marketersmedia.com/neurodiagnostics-market-to-grow-with-cagr-of-7-during-2019-2026-exclusive-report-by-brisk-insights/515142

Source: MarketersMedia

Release ID: 515142

Latest Releases

Subscribe and Receive exclusive insider tips and tricks on Press Release.

Follow Us

Copyright © 2012 - 2019 MarketersMEDIA – Press Release Distribution Services – News Release Distribution Services. All Rights Reserved.

Powered by Semantics BigData Analytics (SBDA).